Your browser doesn't support javascript.
loading
Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis.
Nugroho, Cahyo Wibisono; Suryantoro, Satriyo Dwi; Yuliasih, Yuliasih; Rosyid, Alfian Nur; Asmarawati, Tri Pudy; Andrianto, Lucky; Setiawan, Herley Windo; Mahdi, Bagus Aulia; Windradi, Choirina; Agustin, Esthiningrum Dewi; Fajar, Jonny Karunia.
Afiliação
  • Nugroho CW; Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
  • Suryantoro SD; Universitas Airlangga Hospital, Surabaya, East Java, 60115, Indonesia.
  • Yuliasih Y; Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
  • Rosyid AN; Universitas Airlangga Hospital, Surabaya, East Java, 60115, Indonesia.
  • Asmarawati TP; Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
  • Andrianto L; Universitas Airlangga Hospital, Surabaya, East Java, 60115, Indonesia.
  • Setiawan HW; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
  • Mahdi BA; Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
  • Windradi C; Universitas Airlangga Hospital, Surabaya, East Java, 60115, Indonesia.
  • Agustin ED; Universitas Airlangga Hospital, Surabaya, East Java, 60115, Indonesia.
  • Fajar JK; Department of Anesthesiology and Reanimation, Faculty of Medicine, Airlangga University, Surabaya, East Java, 60132, Indonesia.
F1000Res ; 10: 73, 2021.
Article em En | MEDLINE | ID: mdl-33763201

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: F1000Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais Humanizados / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: F1000Res Ano de publicação: 2021 Tipo de documento: Article